Founded in 2018, Vivera is an industry-disrupting pharmaceutical company committed to developing novel therapies for various indications, including opioid deterrence and cessation, non-addictive solutions for pain management, and pharmaceutical and medical device products. The Company comprises six divisions, each with a unique mission working synergistically to support Vivera’s core mission of putting patients first.
